| 2024/04/18 17:32:13 | |
|---|---|
| Price | |
| 98.81 EUR | |
| Difference | 0.15% (0.15) |
General attributes
| ISIN | US0028241000 |
| Symbol | ABT |
| Exchange | Vienna Stock Exchange |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 171,220 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 99.61 EUR |
| High | 99.61 EUR |
| Low | 98.81 EUR |
| Close (prev. day) | 98.66 EUR |
| VWAP | 104.16 EUR |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 2 |
| Last size | 0 |
Futures and Options
| Related Futures | 15 |
| Related Options | - |
PDF Downloads
| Company report: ABBOTT LABORATORIES |  |
Add Benchmark:
Recent research
| Date | Headline | Download | |
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/02/14 |
|
Global Equity Ratings |
|
| 2024/01/23 |
|
Global Equity Ratings |
|
| 2024/04/18 17:32:13 | |
|---|---|
| Price | |
| 98.81 EUR | |
| Difference | 0.15% (0.15) |
General attributes
| ISIN | US0028241000 |
| Symbol | ABT |
| Exchange | Vienna Stock Exchange |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 171,220 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | - |
| Ask (Ask size) | - |
| Open | 99.61 EUR |
| High | 99.61 EUR |
| Low | 98.81 EUR |
| Close (prev. day) | 98.66 EUR |
| VWAP | 104.16 EUR |
| Volume (pcs) | 0 |
| Trading volume | 0.00 |
| Number of trades | 2 |
| Last size | 0 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +10.18% | +4.01% | -3.97% |
| Perf (abs.) | +9.13 | +3.81 | -4.09 |
| Beta | 0.41 | 0.45 | 0.73 |
| Volatility | 18.50 | 18.61 | 21.49 |
Add Benchmark:
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 101.37 EUR (2) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 104.46 EUR (3) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 103.10 EUR (6) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 98.49 EUR (3) |
| YTD High | date | 111.10 EUR (2024/03/08) |
| YTD Low | date | 98.66 EUR (2024/04/17) |
| 52 Weeks High | date | 111.10 EUR (2024/03/08) |
| 52 Weeks Low | date | 85.66 EUR (2023/10/13) |
All listings for ABBOTT LABORATORIES
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Xetra | 2024/04/18 | 17:35 | 98.73 EUR | 0.13 | 25 |
| Vienna Stock Exchange | 2024/04/18 | 17:32 | 98.81 EUR | 0.00 | 2 |
| Tradegate | 2024/04/18 | 22:26 | 98.91 EUR | 0.18 | 44 |
| Stuttgart | 2024/04/18 | 21:57 | 98.83 EUR | 0.00 | 6 |
| SIX Swiss Exchange | 2024/02/19 | 17:31 | 93.00 CHF | 0.00 | 1 |
| NYSE | 2024/04/18 | 22:00 | 105.27 USD | 768.18 | 90,365 |
| Munich | 2024/04/18 | 08:04 | 99.20 EUR | 0.00 | 1 |
| London Stock Exchange | 2024/04/09 | 15:30 | 110.88 USD | 0.04 | 1 |
| Hanover | 2024/04/18 | 08:00 | 99.04 EUR | 0.00 | 3 |
| Hamburg | 2024/04/18 | 08:00 | 99.04 EUR | 0.00 | 3 |
| Frankfurt | 2024/04/18 | 17:02 | 99.00 EUR | 0.02 | 1 |
| Duesseldorf | 2024/04/18 | 19:31 | 98.28 EUR | 0.00 | 5 |
| Berlin | 2024/04/18 | 20:30 | 98.30 EUR | 0.00 | 18 |
Company Logo
Contact Details
| ABBOTT LABORATORIES |
| - - |
| 100 Abbott Park Road - 60064-6400 Abbott Park |
| Telefon: +1-224-667-6100 |
| Fax: + |
| E-mail: - |
PDF Downloads
| Company report: ABBOTT LABORATORIES | |
Company Profile
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL. |
Members of Management Board
| Robert Alpern | Member of Board of Directors |
| Sally Blount | Member of Board of Directors |
| Claire Babineaux-Fontenot | Member of Board of Directors |
| Daniel Starks | Member of Board of Directors |
| Darren McDew | Member of Board of Directors |
| John Stratton | Member of Board of Directors |
| Michael O'Grady | Member of Board of Directors |
| Michael Roman | Member of Board of Directors |
| Michelle Kumbier | Member of Board of Directors |
| Nancy McKinstry | Member of Board of Directors |
| Paola Gonzalez | Member of Board of Directors |
| Robert B. Ford | Chairman of Managing Board |
| Andrea F. Wainer | Member of Executive Committee |
| Daniel Salvadori | Member of Executive Committee |
| Hubert L. Allen | Member of Executive Committee |
| Lisa D. Earnhardt | Member of Executive Committee |
| Mary K. Moreland | Member of Executive Committee |
| Robert E. Funck, Jr. | Member of Executive Committee |